Hamostaseologie 2022; 42(03): e1
DOI: 10.1055/s-0042-1751244
Erratum

Erratum: Effect of DDAVP on Platelet Activation and Platelet-Derived Microparticle Generation

Matthieu Persyn
1   Service d'Hématologie Biologique, CHU de Nantes, Nantes, France
,
Nicolas Athanase
1   Service d'Hématologie Biologique, CHU de Nantes, Nantes, France
,
Marc Trossaërt
1   Service d'Hématologie Biologique, CHU de Nantes, Nantes, France
2   Centre de Traitement de l'Hémophilie, CHU de Nantes, Nantes, France
,
Marianne Sigaud
1   Service d'Hématologie Biologique, CHU de Nantes, Nantes, France
2   Centre de Traitement de l'Hémophilie, CHU de Nantes, Nantes, France
,
Catherine Ternisien
1   Service d'Hématologie Biologique, CHU de Nantes, Nantes, France
2   Centre de Traitement de l'Hémophilie, CHU de Nantes, Nantes, France
,
Marie C. Béné
1   Service d'Hématologie Biologique, CHU de Nantes, Nantes, France
,
Marc Fouassier
1   Service d'Hématologie Biologique, CHU de Nantes, Nantes, France
2   Centre de Traitement de l'Hémophilie, CHU de Nantes, Nantes, France
› Institutsangaben
 

    Hamostaseologie 2021. DOI: 10.1055/a-1476-7768

    Published online: 2021-06-17.

    In the above article, in the “Abstract” on the first page, in paragraph “Results”, one sentence is incorrect. Correct is:

    DDAVP induced a significant decrease of platelet counts and volume. Only small changes of P-selectin expression and PAC-1 binding were observed. After DDAVP, PMPs increased by 120% (n = 6) or decreased by 18% (n = 7), thus segregating two groups of patients. The decrease in platelet counts and volume remained significant in the group of responders.

    In the above article, on the third page (right column, paragraph “PMPs Do Not Increase in all Patients after DDAVP Infusion”, the fourth line from below), one number is incorrect. Correct is:

    In the group of nonresponders, there was an average apparent decrease of PMPs (18%) from 1,858/μL (range: 1,328–2,544) to 1,524/μL (range: 1,321–1,752).


    #

    Conflicts of Interests

    The authors declare that they have no conflict of interest.

    Address for correspondence

    Marc Fouassier, MD
    Centre de Traitement de l'Hémophilie – CHU Hôtel-Dieu
    1 Place Alexis Ricordeau, 44093 NANTES Cedex 1
    France   

    Publikationsverlauf

    Artikel online veröffentlicht:
    30. Juni 2022

    © 2022. Thieme. All rights reserved.

    Georg Thieme Verlag KG
    Rüdigerstraße 14, 70469 Stuttgart, Germany